Executive VP, COO of BioReference Laboratories Inc. (BRLI, Financial) Howard Dubinett sells 25,000 shares of BRLI on 06/14/2010 at an average price of $23.28 a share.
Bioreference Laboratories Inc. has a market cap of $654.3 million; its shares were traded at around $23.57 with a P/E ratio of 28.1 and P/S ratio of 1.8.
BRLI is in the portfolios of Manning & Napier Advisors, Inc, Jim Simons of Renaissance Technologies LLC.
Bioreference Laboratories Inc. has a market cap of $654.3 million; its shares were traded at around $23.57 with a P/E ratio of 28.1 and P/S ratio of 1.8.
BRLI is in the portfolios of Manning & Napier Advisors, Inc, Jim Simons of Renaissance Technologies LLC.
CEO Recent Trades:
- Sell: President, CEO, 10% Owner Marc Grodman sold 6,905 shares of BRLI stock on 12/23/2009 at the average price of 38.53. Marc Grodman owns at least 1,162,733 shares after this. The price of the stock has decreased by 38.83% since.
CFO Recent Trades:
- Sell: Sr. VP, Sec'y, Treasurer, CFO Sam Singer sold 15,000 shares of BRLI stock on 01/05/2010 at the average price of 40.02. Sam Singer owns at least 38,016 shares after this. The price of the stock has decreased by 41.1% since.
Directors and Officers Recent Trades:
- Sell: Executive VP, COO Howard Dubinett sold 10,000 shares of BRLI stock on 03/11/2010 at the average price of 44.97. Howard Dubinett owns at least 215,069 shares after this. The price of the stock has decreased by 47.59% since.
